市场调查报告书
商品编码
946802

肝炎诊断检验市场-成长,趋势,预测(2020年~2025年)

Hepatitis Diagnostic Test Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

从传统的技术大幅度转移到分子诊断,扩大了程序的能力,缩短结果出来的时间。肝炎测试中使用的分子诊断方法包括基因测试,以确认致病病毒的确切菌株。所使用的核酸测定包括HCV RNA和HBV DNA分析测试。因此,这种先进的检测技术的可用性刺激整个市场的成长。此外,肝炎的高流行也有望推动市场成长。

本报告提供肝炎诊断检验市场相关调查,市场概要,各实验类型,各地区的趋势,参与企业的简介等资讯。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 市场概要
  • 市场成长要素
    • 肝炎增加的负担
    • 肝炎的诊断的分子诊断的简介
    • 疾病相关意识的高涨
  • 市场阻碍因素
    • 肝炎检验的有限设施或服务
    • 可靠性高低成本的HBV及HCV诊断的获取限制
  • 波特的五力分析

第5章 市场细分化

  • 各试验类型
    • 血液检验
    • 影像检查
    • 肝脏切片检查
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第6章 竞争情形

  • 企业简介
    • Abbott Laboratories
    • Danaher Corporation (Beckman Coulter Inc)
    • BioMerieux SA
    • Bio-Rad Laboratories Inc
    • Diasorin SpA
    • F. Hoffmann-La Roche AG
    • Hologic Inc
    • MedMira Inc
    • Qaigen Inc
    • Siemens Healthineers

第7章 市场机会及未来趋势

目录
Product Code: 62299

The major shift from conventional technologies to molecular diagnostics has amplified the competence of procedures and has to pull down the dispatch time for results. Molecular diagnostics used in hepatitis testing involve genetic tests to confirm the exact strain of the causative virus. The nucleic acid assays used include HCV RNA and HBV DNA analysis tests. Hence, the availability of such advanced detection techniques is spurring the overall market growth. Furthermore, the high prevalence of hepatitis is also expected to fuel market growth. According to the U.S. Department of Health & Human Services, in 2018, most adults in their 20s and 30s made up 36.5% of newly reported chronic hepatitis C infections and this is expected to increase in the forecast period. Along with these other factors, such as increasing awareness regarding the disease may lead to the further growth of the market.

Key Market Trends

Immunoassay Segment is Expected to Show Good Growth Over the Forecast Period

Immunoassays are bioanalytical methods, in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. The versatile applications and ease of diagnosis have made immunoassay quite popular in recent years. Also, with the rising cases of hepatitis, the market is expected to show better growth. According to WHO, in 2019, Hepatitis B prevalence is highest in the WHO Western Pacific region and the WHO African region, where 6.2% and 6.1% of the adult population is infected respectively. Hence, owing to the aforementioned factors, along with rising technological advancements are expected to further drive the market growth.

North America is Expected to Retain Largest Market Share Over the Forecast Period

North America dominated the market with the largest revenue share. The availability of advanced diagnostic tools and high awareness regarding these products are the key factors driving the growth of the market in North America. The accelerated growth in the Canadian market can be attributed to the initiatives of the government and non-government organizations. For instance, the Public Health Agency of Canada organized the World Hepatitis Day in order to increase awareness regarding hepatitis detection. Thereby, leading to a demand surge for hepatitis detection in the country.

Competitive Landscape

The market is dominated by few global players which compete primarily on the basis of technological innovations. Key market players include Abbott Laboratories, Danaher Corporation, BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, MedMira Inc, Qaigen Inc, and Siemens Healthineers.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Hepatitis
    • 4.2.2 Introduction of Molecular Diagnostics for the Diagnosis of Hepatitis
    • 4.2.3 Increasing Awareness Regarding The Disease
  • 4.3 Market Restraints
    • 4.3.1 Limited Facilities or Services For Hepatitis Testing
    • 4.3.2 Limited Access to Reliable and Low-Cost HBV and HCV Diagnostics
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Blood Tests
      • 5.1.1.1 Liver Function Tests
      • 5.1.1.2 Immunoassays
      • 5.1.1.3 Nucleic Acid Tests
    • 5.1.2 Imaging Test
    • 5.1.3 Liver Biopsy
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Danaher Corporation (Beckman Coulter Inc)
    • 6.1.3 BioMerieux SA
    • 6.1.4 Bio-Rad Laboratories Inc
    • 6.1.5 Diasorin S.p.A
    • 6.1.6 F. Hoffmann-La Roche AG
    • 6.1.7 Hologic Inc
    • 6.1.8 MedMira Inc
    • 6.1.9 Qaigen Inc
    • 6.1.10 Siemens Healthineers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS